oxaflozane oxaflozane oxaflozane (inn) (brand name conflictan) is an antidepressant and anxiolytic drug that was introduced by solvay in france in 1982 for the treatment of depression but has since been discontinued. it is a prodrug of flumexadol (n-dealkyloxaflozane; 2-(3-trifluoromethylphenyl)morpholine; cerm-1841 or 1841-cerm), which is reported to act as an agonist of the serotonin 5-ht1a (pki = 7.1) and 5-ht2c (pki = 7.5) receptors and, to a much lesser extent, of the 5-ht2a (pki = 6.0) receptor. in addition to its serotonergic properties, oxaflozane may also produce anticholinergic side effects at high doses, namely in overdose. oxaflozaneclinical datatrade namesconflictanother namescerm-1766routes ofadministrationoralatc coden06ax10 (who) legal statuslegal status in general: ℞ (prescription only) identifiers iupac name 4-propan-2-yl-2-morpholine cas number26629-87-8 yhcl: 26629-86-7 ypubchem cid432824chemspider382782uniiv4wlw77v5qhcl: e10fw59d1i ykeggd07340comptox dashboard (epa)dtxsid50865308 echa infocard100.043.490 chemical and physical dataformulac14h18f3nomolar mass273.299 g·mol−13d model (jsmol)interactive image smiles o1ccn(c(c)c)cc1c2cc(c(f)(f)f)ccc2